Showing 1 - 8 results of 8 for search 'Rebecca Germino', query time: 0.03s Refine Results
  1. 1
    Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: Pooled analysis from four phase 3 trials

    Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: Pooled analysis from four phase 3 trials by Steven R. Feldman, Braulio Gomez, Xiangyi Meng, Rebecca Germino

    Published 2021-10-01
    Get full text
    Article
  2. 2
    Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib

    Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitin... by Vibeke Strand, Jeffrey Kaine, Rieke Alten, Gene Wallenstein, Annette Diehl, Harry Shi, Rebecca Germino, Christopher W. Murray

    Published 2020-10-01
    Get full text
    Article
  3. 3
    US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry

    US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry by Bruce E. Strober, Rebecca Germino, Adriana Guana, Jeffrey D. Greenberg, Heather J. Litman, Ning Guo, Mark Lebwohl

    Published 2020-05-01
    Get full text
    Article
  4. 4
    Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis

    Itch as Major Mediator of Effect of Tofacitinib on Health-Related Quality of Life in Psoriatic Arthritis: A Mediation Analysis by Peter C. Taylor, Andrew G. Bushmakin, Joseph C. Cappelleri, Pamela Young, Rebecca Germino, Joseph F. Merola, Gil Yosipovitch

    Published 2021-09-01
    Get full text
    Article
  5. 5
    Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies

    Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies by Peter C. Taylor, Andrew G. Bushmakin, Joseph C. Cappelleri, Pamela Young, Rebecca Germino, Joseph F. Merola, Gil Yosipovitch

    Published 2022-07-01
    Get full text
    Article
  6. 6
    Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment

    Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment by Flora McErlane, Marco Boeri, Cooper Bussberg, Joseph C. Cappelleri, Rebecca Germino, Lori Stockert, Caroline Vass, Adam M. Huber

    Published 2023-10-01
    Get full text
    Article
  7. 7
    Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies

    Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies by Charlie W. Lees, J. Jasper Deuring, Michael Chiorean, Marco Daperno, Gianluca Bonfanti, Rebecca Germino, Pritha Bhadra Brown, Irene Modesto, Roger A. Edwards

    Published 2021-11-01
    Get full text
    Article
  8. 8
    Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)

    Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b... by Boulos Haraoui, Janet Pope, Edward C Keystone, Eduardo Mysler, Tatjana Lukic, Harry Shi, Stanley B Cohen, Rebecca Germino, Lori Stockert, Annette Diehl, Sujatha Menon, Shixue Liu

    Published 2021-08-01
    Get full text
    Article

Search Tools: